# A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

> **NCT02467387** · PHASE2 · COMPLETED · sponsor: **CardioCell LLC** · enrollment: 23 (actual)

## Conditions studied

- Non-Ischemic Heart Failure

## Interventions

- **DRUG:** Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)
- **DRUG:** Lactated Ringer's Solution

## Key facts

- **NCT ID:** NCT02467387
- **Lead sponsor:** CardioCell LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-01
- **Primary completion:** 2017-05-11
- **Final completion:** 2017-05-11
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467387, "A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02467387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*